Introduction
============

Neonatal mortality remains unacceptably high and the risk is greatest on the first day of life -- these were the conclusions of the 14th annual State of the World's Mothers report, entitled *Surviving the first day*,[@R1] which presented estimates of the risk of maternal, neonatal and first-day deaths in 186 countries for 2011. Worldwide, it was estimated that more than 1 million babies died within 24 hours of birth in 2011, which represented more than one third of all neonatal deaths and 15% of all deaths in children younger than 5 years. The risk was highest in sub-Saharan Africa but the number of deaths was highest in South Asia.

Estimated risks for 2013, which have recently been published, were similar.[@R2] The estimates for 2011 and 2013 were both derived using a modelling approach based on data on live births and neonatal deaths from the United Nations Inter-agency Group for Child Mortality Estimation. Although data from vital registration systems were available for 109 countries, only those from 57 countries were judged to be of high quality -- the proportion of deaths in the first day of life was calculated directly for these countries. For the other 129 countries without high-quality vital registration system data, the proportion of deaths in the first day of life was estimated from country-specific United Nations' data using a neonatal survival curve derived from Demographic and Health Survey data for 79 countries (median reporting date: 1999). Model-based estimates provide essential information on countries lacking high-quality direct assessments: they illustrate the magnitude of the problem, enable cross-country comparisons to be made and help guide health policy and health service planning. However, the estimates must be accurate and up-to-date.

For many countries, epidemiological studies have collected prospective, population-based information on pregnancies, births and newborn deaths that could be used to replace model estimates with high-quality, up-to-date data. We obtained such information from community surveillance systems established as part of large, ongoing or recently completed studies in six low- and lower-middle-income countries in sub-Saharan Africa and South Asia: Bangladesh, Ghana, India, Pakistan, the United Republic of Tanzania and Zambia. The aims of this analysis were to estimate the neonatal mortality rate and the percentage of neonatal deaths occurring within the first 6 and 24 hours of life in these countries and to compare the results with model-based estimates.

Methods
=======

Our analysis involved epidemiological data from population-based, cohort or intervention studies carried out at seven sites in the six countries between 2007 and 2013 and coordinated by the World Health Organization (WHO; [Table 1](#T1){ref-type="table"}; available at: <http://www.who.int/bulletin/volumes/94/10/15-160945>)

###### Studies included, analysis of neonatal mortality in six low- and lower-middle-income countries, 2007--2013

  Characteristic                                                              Study country                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  --------------------------------------------------------------------------- --------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------
  Study site                                                                  Projahnmo area, Sylhet district                                                   7 rural and semi-urban districts in the Brong-Ahafo Region                                                                                         18 rural and semi-urban areas in Haryana State                                                                                           4 peri-urban and 1 urban site in Karachi city                                                                                                 Naushahro Feroze, a rural district of Sindh Province                                                                                                                                Pemba Island                                                                                                                                                   45 clusters in Southern Province
  Approximate population under surveillance, *n*                              182 000                                                                           600 000                                                                                                                                            550 000                                                                                                                                  274 000                                                                                                                                       243 000                                                                                                                                                                             400 000                                                                                                                                                        ND^b^
  Proportion of women who had ≥ 1 antenatal care visit, %                     60                                                                                97                                                                                                                                                 59                                                                                                                                       75                                                                                                                                            78                                                                                                                                                                                  85                                                                                                                                                             96
  Proportion of women with a skilled birth attendant present at delivery, %   14                                                                                64                                                                                                                                                 50                                                                                                                                       59                                                                                                                                            56                                                                                                                                                                                  51                                                                                                                                                             55
  Study period                                                                2007--2009                                                                        2008                                                                                                                                               2008--2010                                                                                                                               2011                                                                                                                                          2010--2012                                                                                                                                                                          2009--2013                                                                                                                                                     2011--2013
  Type of study                                                               Cluster randomized trial                                                          Two cluster randomized trials                                                                                                                      Cluster randomized trial                                                                                                                 Cohort study (Health and Demographic Surveillance system data)                                                                                Cluster randomized trial                                                                                                                                                            Individually randomized trial                                                                                                                                  Cluster randomized trial
  Intervention                                                                Chlorhexidine applied to the umbilical cord stump                                 Low-dose vitamin A supplementation for women of reproductive age (ObaapaVitA trial) and home visits by community health workers (Newhints trial)   Implementation of Integrated Management of Neonatal and Childhood Illness programme, which included home visits for early newborn care   No intervention                                                                                                                               Intervention package for mothers and babies implemented by traditional birth attendants and lady health workers                                                                     Chlorhexidine applied to the umbilical cord stump                                                                                                              Chlorhexidine applied to the umbilical cord stump
  Identification of pregnancy                                                 Noted during home visits carried out by community health workers every 2-months   Noted during home visits carried out by trained field workers every 4 weeks                                                                        Noted during monthly home visits by trained study workers                                                                                Noted during home visits carried out by community health workers every 3 months                                                               Noted during home visits carried out by community health workers every 3 months                                                                                                     Noted during weekly contacts with families made by community health workers                                                                                    Pregnant women enrolled during antenatal visits and community outreach programmes
  Identification of birth                                                     Noted during a home visit carried out at birth                                    Noted during home visits carried out by trained field workers every 4 weeks                                                                        Noted during monthly home visits by trained study workers or during follow-up visits to pregnant women                                   Reported by the birth attendant and confirmed by calling the family or noted during a surveillance home visit carried out by a study worker   Reported by the birth attendant and confirmed by calling the family, reported by a lady health worker or village volunteer or noted during a surveillance visit by a study worker   Reported to a central information system by a health worker in the local maternity ward, a maternal and child health worker or a traditional birth attendant   Notified by a staff member at a facility or by a family member at a visit or by phone
  Identification of neonatal death                                            Noted during the 6 home visits made during the neonatal period                    Noted during the home visit made during the neonatal period or the home visit made after the neonatal period                                       Noted during the home visit made at the end of the neonatal period on day 29                                                             Noted during the 6 home visits made during the neonatal period                                                                                Noted during the 3 home visits made during the neonatal period or on a quarterly home visit                                                                                         Noted during the 5 home visits made during the neonatal period                                                                                                 Noted during the 5 home visits made during the neonatal period
  Groups included in the analysis                                             Control clusters only                                                             Full trial cohorts                                                                                                                                 Control clusters only                                                                                                                    Full trial cohort                                                                                                                             Control clusters only                                                                                                                                                               Full trial cohort                                                                                                                                              Control clusters only

ND: not determined.

^a^ For Ghana, data came from a combination of two trials: (i) the ObaapaVitA trial, which collected data between January and October 2008; and (ii) the Newhints trial, which collected data during the preparatory phase in November and December 2008 -- the full intervention did not start until June 2009.

^b^ The population covered by the trial in Zambia was not determined because women were enrolled at antenatal clinics or during community outreach.

Intervention studies that recruited newborn babies were excluded as some deaths that occurred before enrolment could have been missed. Data were derived from five cluster randomized trials, one individually randomized trial and one cohort study. Three trials evaluated the effect of applying chlorhexidine to the umbilical cord on neonatal mortality, one examined low-dose vitamin A supplementation for women of reproductive age and three involved home visits by community health workers. Together the trials included over 2 million women in predominantly rural communities. All studies included a community-based surveillance system involving home visits by trained field workers who collected data on vital events, including pregnancies, births, deaths, illness and migration, every one to three months. For the analysis, data from both intervention and control arms were pooled if there was no evidence that the intervention affected neonatal mortality. Otherwise, only data from the control arm were included.

For Bangladesh, the analysis used data from the control arm of a cluster randomized trial evaluating the effect of different umbilical cord cleansing regimens on neonatal mortality and infection.[@R3]^,^[@R4] Between 2007 and 2009, community health workers made home visits every two months. The dates and times of births were recorded soon after birth and the dates and times of deaths were recorded during postnatal visits on days 1, 3, 6, 9, 15 and 28. For Ghana, data on all participants in two cluster randomized trials were used because the interventions had no significant effect on neonatal mortality.[@R5]^,^[@R6] The trials were conducted in seven predominantly rural districts in 2008: one examined the effect of low-dose vitamin A supplementation on maternal and infant mortality and one evaluated the effect of a home visit programme on neonatal mortality and newborn care practices. Trained field workers made home visits every four weeks, at which they recorded births and deaths. For each neonatal death, a verbal autopsy was performed by a trained supervisor, who determined whether or not the death occurred within the first 24 hours. For India, data from the control arm of a cluster randomized trial on the effect of an Integrated Management of Neonatal and Childhood Illness programme on neonatal and infant mortality were used.[@R7] The trial was conducted in rural and semi-urban areas of Haryana State between 2008 and 2010. Home visits took place monthly and all households with a live birth were visited on day 29 to document the vital status of the infant. As in Ghana, an independent verbal autopsy was performed for any death.

For Pakistan, data came from a Health and Demographic Surveillance system covering approximately 274 000 people in urban and peri-urban Karachi and from the control arm of cluster randomized trial in Sindh. In Karachi, data were collected by community health workers who visited households every three months in 2011.[@R8] In Sindh, the trial investigated the effect of interventions involving traditional birth attendants and Lady Health Workers on birth asphyxia, sepsis and the number of low-birth-weight infants and, consequently, on neonatal mortality. For the United Republic of Tanzania, data from all participants in an individually randomized trial examining the effect of applying chlorhexidine to the umbilical cord stump on neonatal mortality were used because the intervention had no significant effect. The trial was conducted on Pemba Island and involved health-care workers in the local maternity ward, maternal and child health workers and traditional birth attendants. All births were registered centrally and households where a birth occurred were visited by a field supervisor; 90% of visits were made within 12 hours of delivery. The date and time of birth were confirmed with the birth attendant. For Zambia, data from the control arm of a cluster randomized trial on the application of chlorhexidine were used. The trial was conducted in the Southern Province between 2011 and 2013.[@R9] As over 95% of women attended antenatal clinics during pregnancy, trial enrolment took place at health centres and during community outreach programmes conducted by health workers. Data on births and deaths were collected through a community-based birth notification system and during home visits after delivery.

Statistical analysis
--------------------

At all sites, a neonatal death was defined as a death within the first 28 days of life (i.e. day 0 to day 27). For Bangladesh, India, the United Republic of Tanzania and Zambia, we estimated mortality within the first 24 hours directly using the difference between the time and date of birth and the time and date of death. For Ghana, the occurrence of death within the first 24 hours was determined by verbal autopsy and, in Pakistan, deaths that occurred on the day of birth were taken as deaths that occurred within the first 24 hours. Mortality in the first 24 hours of life was expressed as deaths per 1000 live births and as a percentage of all neonatal deaths. In addition, mortality in the first six hours of life was calculated for the four sites where relevant data were available. For comparison, we used modelling estimates of neonatal mortality, mortality within the first 24 hours of birth and the percentage of all neonatal deaths occurring within 24 hours for each country derived by Oza et al.[@R2]

Results
=======

The total number of live births included in the analysis was 149 570: the number in each country ranged from 11 143 in Bangladesh to 44 450 in the United Republic of Tanzania ([Table 2](#T2){ref-type="table"}). The pooled neonatal mortality rate across all studies was 30.5 per 1000 live births and country-specific neonatal mortality rates ranged from 13.6 per 1000 live births (95% confidence interval, CI: 12.0--15.3) in Zambia to 47.4 per 1000 (95% CI: 44.9--49.9) in Pakistan. Overall, mortality within the first 24 hours was 14.1 per 1000 live births -- the lowest rate was 5.1 per 1000 live births in Zambia and the highest was 20.1 per 1000 live births in India. The percentage of neonatal deaths occurring within the first 24 hours was 46.3% overall: the figure ranged from 36.2% (95% CI: 33.6--38.8) in Pakistan to 65.5% (95% CI: 62.0--69.0) in the United Republic of Tanzania. At the four sites where data on deaths within the first six hours were available, the mortality rate was 8.3 per 1000 live births overall, which corresponded to 31.9% of the overall neonatal mortality rate at these sites. The proportion of neonatal deaths that occurred in the first 6 hours ranged from 17.5% in Zambia to 36.0% in the United Republic of Tanzania ([Table 2](#T2){ref-type="table"}). [Fig. 1](#F1){ref-type="fig"} shows a comparison of the neonatal mortality rates we observed in the six study countries with the corresponding rates derived in a modelling-based study by Oza et al.[@R2] According to the modelling study, 36% of neonatal deaths would be expected to occur in the first 24 hours of life in our six study countries, which is lower than the average of 46% we observed.

###### Live births and neonatal mortality, six low- and lower-middle-income countries, 2007--2013

  Parameter                                                                             Bangladesh          Ghana               India               Pakistan            United Republic of Tanzania   Zambia              Total
  ------------------------------------------------------------------------------------- ------------------- ------------------- ------------------- ------------------- ----------------------------- ------------------- -------------------
  Approximate population under surveillance, *n*                                        182 000             600 000             550 000             517 000             400 000                       ND^a^               \> 2 000 000
  Study period                                                                          2007--2009          2008                2008--2010          2010--2012          2009--2013                    2011--2013          NA
  Live births during the study period, no.                                              11 143              15 461              30 920              28 250              44 450                        19 346              149 570
  Neonatal deaths,^b^ no.                                                               442                 484                 1 326               1 338               714                           263                 4 567
  Neonatal mortality rate, deaths per 1000 live births (95% CI)                         39.7 (36.1--43.5)   31.3 (28.6--34.2)   42.9 (40.7--45.2)   47.4 (44.9--49.9)   16.1 (14.9--17.2)             13.6 (12.0--15.3)   30.5 (29.7--31.4)
  Neonatal deaths in the first 24 hours of life, no.                                    182                 263                 620                 484                 468                           98                  2 115
  Neonatal mortality rate in the first 24 hours, deaths per 1000 live births (95% CI)   16.3 (14.1--18.9)   17.0 (15.0--19.2)   20.1 (18.6--21.7)   17.1 (15.7--18.8)   10.5 (9.6--11.5)              5.1 (4.1--6.2)      14.1 (13.5--14.8)
  Proportion of neonatal deaths occurring in the first 24 hours, % (95% CI)             41.2 (36.5--45.9)   54.3 (49.8--58.8)   46.8 (44.0--49.5)   36.2 (33.6 38.8)    65.5 (62.0--69.0)             37.3 (31.4--43.4)   46.3 (44.9--47.8)
  Neonatal deaths in the first 6 hours of life, no.                                     113                 ND^c^               460                 ND^c^               257                           46                  876
  Neonatal mortality rate in the first 6 hours, deaths per 1000 live births (95% CI)    10.1 (8.4--12.2)    ND^c^               14.9 (13.6--16.3)   ND^c^               5.8 (5.1--6.5)                2.4 (1.7--3.2)      8.3 (7.7--8.8)
  Proportion of neonatal deaths occurring in the first 6 hours, % (95% CI)              25.6 (21.6--30.0)   ND^c^               34.7 (32.1--37.3)   ND^c^               36.0 (32.5--39.6)             17.5 (13.1--22.6)   31.9 (30.2--33.7)
                                                                                                                                                                                                                          

CI: confidence interval; NA: not applicable; ND: not determined.

^a^ The population covered by the trial in Zambia was not determined because women were enrolled at antenatal clinics or during community outreach.

^b^ Neonatal deaths in the first 28 days of life.

^c^ The time of death during the first day was not available for this study.
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Discussion
==========

Our main finding was that, overall, a little under half of all neonatal deaths in the study populations occurred within 24 hours of birth -- the figure ranged from 36% to 66% across the study sites -- and about one in three neonatal deaths occurred within six hours of birth. Our data confirm that neonatal mortality remains high in many low- and lower-middle-income countries.

Our study has several strengths. The total study population was large and data on almost 150 000 live births and over 4500 neonatal deaths were included. Moreover, as the data came from large, high-quality and prospective surveillance systems that were established to capture population-based data on births and deaths, the numerators and denominators were accurate. In particular, our data were more likely to be complete than data from large country-wide surveys, such as Demographic and Health Surveys, which have, in the past, underestimated the true burden of rare events such as neonatal deaths and stillbirths.[@R10] In addition, nationally representative surveys suffer from recall bias, which may be particularly important for deaths occurring very close to birth. Many mothers may report neither the birth nor the death of such babies during surveys. The studies we analysed prospectively identified and followed up all births in the target populations and the possibility that stillbirths were misclassified as very early neonatal deaths was minimized in these studies by active surveillance and careful verbal autopsy.

Comparison with model-based estimates
-------------------------------------

Generally the neonatal mortality rates we observed were significantly different from the model-based estimates: the 95% CI for the observed neonatal mortality rate did not include the modelled estimate for any country except Ghana. Moreover, the observed proportion of neonatal deaths occurring in the first 24 hours was significantly higher than the modelled estimate of 36% for all countries except Pakistan and Zambia. In Pakistan, the observed proportion of deaths in the first 24 hours may have been underestimated because, in one trial, only deaths recorded on the date of birth were regarded as having occurred in the first 24 hours. This explanation does not apply to Zambia, however.

Our observation that a higher proportion of neonatal deaths occurred in the first 24 hours than predicted by modelling must be interpreted in the context of the overall neonatal mortality rate. The proportion of neonatal deaths occurring in the first day of life is generally higher when the neonatal mortality rate is low: in 2011, a proportion of 35% was reported in sub-Saharan Africa where the neonatal mortality rate was 34 per 1000 live births compared with a proportion of 67% for developed countries where the neonatal mortality rate was 3 per 1000 live births.[@R1] In our study, the observed neonatal mortality rate was higher than the modelled estimate for Bangladesh, Ghana, India and Pakistan but lower for the United Republic of Tanzania and Zambia. Although no special criteria were used to select the study populations, these populations did live in geographical areas with high mortality. Consequently, the neonatal mortality rates in these settings may have been higher than the national averages. Given higher neonatal mortality rates, the proportion of deaths occurring in the first 24 hours would have been expected to be lower, but we found the opposite. This observation has important implications for maternal and newborn health programmes in low- and lower-middle-income countries because most neonatal deaths globally occur in populations similar to our study populations, in which the neonatal mortality rate is likely to be near or above the national average.

The neonatal mortality rates observed in our study would have been expected to be lower than modelled estimates because the data were collected more recently: between 2007 and 2013 compared with a median survey year of 1999 for the data used in the model. However, improvements could have subsequently taken place in the study areas. In particular, there have been many advances in newborn care in recent years in settings where access to adequate health care is not universal. For example, in a large trial in Ghana, home visits by community health workers to promote essential newborn care practices have been shown to reduce neonatal mortality by 12% and have the potential to reduce childhood mortality by 4.9%.[@R6] In our study, the observed neonatal mortality rate was lower than the modelled estimate only in the United Republic of Tanzania and Zambia. We believe the higher rates we found in the other four countries were due to differences in methods used: our estimates were based on prospectively defined population groups in which all births were followed up whereas the model's estimates were based on cross-sectional surveys, which are more prone to recall bias and, consequently, to underestimation of the real neonatal mortality rate. Although the provision of intrapartum and postnatal care by skilled birth attendants is known to be crucial for neonatal survival, we observed no clear relationship between coverage by skilled birth attendants or antenatal care and neonatal mortality. This finding implies that neonatal mortality and the proportion of neonatal deaths in the first 24 hours may depend on other factors, such as: (i) the quality of the intrapartum and postnatal care; (ii) the characteristics of the infant, such as birth weight; or (iii) socioeconomic factors, such as maternal literacy.

Limitations
-----------

One limitation of our analysis is that our estimates of neonatal mortality were not nationally representative because the studies were conducted in predominantly rural areas. However, our findings are generalizable to similar, vulnerable populations in low- and lower-middle-income countries because the neonatal mortality rates we observed were not influenced by averaging across different population types. Another limitation is the variation between studies in the surveillance carried out to identify neonatal deaths. Although frequent home visits were made during the neonatal period at most sites, only one or two visits took place in Ghana and India. However, the dates and times of births and deaths were confirmed at all sites by verbal autopsies conducted by experienced field workers within three months of the death. These field workers spent one or two hours with families to determine the circumstances surrounding the death and its timing. Although there is a possibility that the time of death was recalled incorrectly, recall bias is substantially greater in surveys like Demographic and Health Surveys, where the interview may take place several months or even years after a neonatal death. Another limitation of our study is that the exact time of death was not available in Pakistan, where the date of birth was used to determine whether the death occurred within the first 24 hours of life. Finally, in Zambia, pregnant women enrolled at health-care facilities during antenatal visits and during community outreach programmes -- they were not identified by routine community-based surveillance.

In conclusion, our findings suggest that maternal and child health programmes in low- and lower-middle-income countries should focus more on preventing deaths within the first 24 hours of life. This will require access to high-quality care during labour and immediately after birth. Several possible life-saving interventions are effective, cost little and are relatively simple to provide in most settings: (i) resuscitation of babies who are not breathing at birth; (ii) antenatal corticosteroid administration to women in premature labour, as described in recent WHO guidelines;[@R11] and (iii) early kangaroo care.[@R1] It has been estimated that better and more readily available preconception, antenatal, intrapartum and postnatal interventions could reduce neonatal mortality by 71% and reduce the number of stillbirths by 33% by 2025.[@R12] Although great strides were made towards achieving a two-thirds reduction in child mortality between 1990 and 2015, with 19 000 fewer children dying each day in 2015 than in 1990,[@R13] the comprehensive implementation of high-quality and effective obstetric and early newborn care should still be high on the agenda.
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